申请人:Eli Lilly and Company
公开号:US07034045B1
公开(公告)日:2006-04-25
The present invention provides certain monofluoroalkyl derivatives useful for potentiating glutamate receptor function in a mammal and therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders.
本发明提供了一些单氟代烷基衍生物,这些衍生物可用于增强哺乳动物中的谷氨酸受体功能,因此可用于治疗各种疾病,如精神和神经障碍。